Efficacy of self-made anti-dysentery decoction combined with moxibustion on ulcerative colitis patients and its impact on related biochemical indicators
Keywords:
Self-made anti-dysentery decoction, Moxibustion, Ulcerative colitis, Biochemical indicatorsAbstract
Objective: To investigate the effect of self-made anti-dysentery decoction combined with moxibustion on patients with ulcerative colitis (UC) and its effect on related biochemical indicators. Methods: A total of 110 UC patients admitted in our hospital from January 1, 2017 to July 1, 2019 were divided into the observation group and control group according to the random number table method, with 55 cases in each group. The control group was treated with mesalazine, and the observation group was treated with intestinal clearing and anti-dysentery decoction combined with moxibustion and mesalazine. The traditional Chinese medicine syndrome scores, biochemical indicators, and adverse reactions were compared between the two groups of patients. Results: After the treatment, the scores of bloody purulent stool, tenesmus, anal burning pain, short voidings of reddish urine, and yellow and thick tongue coating were significantly lower than those in the two groups before treatment, and the scores in the observation group were significantly lower than the control group; and the white blood cell (WBC), C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) levels of the two groups were significantly lower than those before treatment, and levels in the observation group were significantly lower than the control group; there was no statistical difference in the adverse reactions between the observation group and the control group. Conclusion: Intestinal clearing and anti-dysentery decoction combined with moxibustion can effectively improve the traditional Chinese medicine syndromes of patients with UC, reduce the inflammatory response of patients with good safety.
Published
Data Availability Statement
The data presented in this study are available on request from the corresponding author.Issue
Section
License
Copyright (c) 2021 The Author(s).
This work is licensed under a Creative Commons Attribution 4.0 International License.